OpenURL Connection Search

Select item for more details and to access through your institution.

Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti‐tumour necrosis factor.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 8, p. 1117, doi. 10.1111/apt.14567
By:
- Ben‐Horin, S.;
- Ungar, B.;
- Kopylov, U.;
- Lahat, A.;
- Yavzori, M.;
- Fudim, E.;
- Picard, O.;
- Peled, Y.;
- Eliakim, R.;
- Del Tedesco, E.;
- Paul, S.;
- Roblin, X.
Publication type:
Article
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy: an open-label, prospective and randomised clinical trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 2, p. 142, doi. 10.1111/apt.14106
By:
- Roblin, X.;
- Boschetti, G.;
- Williet, N.;
- Nancey, S.;
- Marotte, H.;
- Berger, A.;
- Phelip, J. M.;
- Peyrin‐Biroulet, L.;
- Colombel, J. F.;
- Del Tedesco, E.;
- Paul, S.;
- Flourie, B.
Publication type:
Article
Undetectable anti-TNF drug levels in patients with long-term remission predict successful drug withdrawal.
Published in:
Alimentary Pharmacology & Therapeutics, 2015, v. 42, n. 3, p. 356, doi. 10.1111/apt.13268
By:
- Ben‐Horin, S.;
- Chowers, Y.;
- Ungar, B.;
- Kopylov, U.;
- Loebstein, R.;
- Weiss, B.;
- Eliakim, R.;
- Del Tedesco, E.;
- Paul, S.;
- Roblin, X.
Publication type:
Article
Appendicectomy as a potential therapy for refractory ulcerative proctitis.
Published in:
Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 2, p. 257, doi. 10.1111/j.1365-2036.2011.04705.x
By:
- Bageacu, S.;
- Coatmeur, O.;
- Lemaitre, J. P.;
- Lointier, P.;
- Del tedesco, E.;
- Phelip, J. M.;
- Roblin, X.
Publication type:
Article
Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study.
Published in:
Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1121, doi. 10.1093/ecco-jcc/jjz040
By:
- Briot, C;
- Faure, P;
- Parmentier, A L;
- Nachury, M;
- Trang, C;
- Viennot, S;
- Altwegg, R;
- Bulois, P;
- Thomassin, L;
- Serrero, M;
- Ah-Soune, P;
- Gilletta, C;
- Plastaras, L;
- Simon, M;
- Dray, X;
- Caillo, L;
- Tedesco, E Del;
- Abitbol, V;
- Zallot, C;
- Degand, T
Publication type:
Article
Combination of C-reactive Protein, Infliximab Trough Levels, and Stable but Not Transient Antibodies to Infliximab Are Associated With Loss of Response to Infliximab in Inflammatory Bowel Disease.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 7, p. 252, doi. 10.1093/ecco-jcc/jjv061
By:
- Roblin, X.;
- Marotte, H.;
- Leclerc, M.;
- Del Tedesco, E.;
- Phelip, J. M.;
- Peyrin-Biroulet, L.;
- Paul, S.
Publication type:
Article
Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
Published in:
Journal of Crohn's & Colitis, 2015, v. 9, n. 6, p. 445, doi. 10.1093/ecco-jcc/jjv063
By:
- Paul, S.;
- Boschetti, G.;
- Rinaudo-Gaujous, M.;
- Moreau, A.;
- Del Tedesco, E.;
- Bonneau, J.;
- Presles, E.;
- Mounsef, F.;
- Clavel, L.;
- Genin, C.;
- Flourié, B.;
- Phelip, J.-M.;
- Nancey, S.;
- Roblin, X.
Publication type:
Article
Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases.
Published in:
American Journal of Gastroenterology (Springer Nature), 2014, v. 109, n. 8, p. 1250, doi. 10.1038/ajg.2014.146
By:
- Roblin, Xavier;
- Rinaudo, M;
- Del Tedesco, E;
- Phelip, J M;
- Genin, C;
- Peyrin-Biroulet, L;
- Paul, S
Publication type:
Article

Found: 8